South London and Maudsley NHS Foundation Trust | |
Front of the Maudsley Hospital | |
Geography | |
---|---|
Location | London, England, United Kingdom |
Organisation | |
Care system | Public NHS |
Hospital type | Specialist mental health care and substance misuse |
Services | |
History | |
Founded | 1999 |
Links | |
Website | http://www.slam.nhs.uk |
Lists | Hospitals in England |
The South London and Maudsley NHS Foundation Trust is an NHS foundation trust based in London, United Kingdom. It comprises three psychiatric hospitals (Bethlem Royal Hospital, Lambeth Hospital and the Maudsley Hospital), the specialist Ladywell Unit based at University Hospital Lewisham, and over 100 community sites and 300 clinical teams.[1]
Each year the Trust provides about 5,000 people with hospital treatment and about 40,000 people with community services.[1] In partnership with King's College London the Trust has major research activities. The Trust forms part of the King's Health Partners academic health science centre and together with the Institute of Psychiatry at King's College London is host to the UK’s only specialist National Institute for Health Research Biomedical Research Centre for mental health.[2] In 2009/10 the Trust had a turnover of £370 million.[2]
The Trust's work on promoting mental health and well-being, developed in partnership with the new economics foundation, has featured in the national media.[3] [4]
Contents |
The Trust provides a wide range of mental health and substance misuse services. The Trust provides care and treatment for a local population of 1.1 million people in south London, as well as specialist services for people from across the country. The Trust provides mental health services for people of all ages from over 100 community sites in south London, three psychiatric hospitals (the Bethlem Royal Hospital, Lambeth Hospital and the Maudsley Hospital) and specialist units based at other hospitals.
The Trust's research activities take place in close partnership with the Institute of Psychiatry, King's College London.
The Trust manages the UK’s only Specialist Mental Health Biomedical Research Centre in partnership with the Institute of Psychiatry, King’s College London. The Centre, which is based on the Maudsley Hospital campus, is funded by the National Institute for Health Research (NIHR). Its aim is to speed up the pace that latest medical research findings are turned into improved clinical care and services.
The team at the Centre are working towards 'personalised medicine' - developing treatments based on individual need. The aim is to diagnose illness more effectively and much earlier, assess which treatments will work best for an individual and then tailor the care they receive accordingly, so that they get better more quickly.
One recent finding to emerge from the BRC is that people suffering serious mental illness can expect to live up to 18 years less than the national average. The research is the first to examine life expectancy for people with specific mental illnesses in the UK and shows that women with schizoaffective disorder and men with schizophrenia are among those most affected, with a reduced life expectancy of 17.5 years and 14.6 years respectively. The study looked at people suffering bipolar disorder, depressive disorders, schizoaffective disorder, schizophrenia and people treated for substance misuse. The findings were published in scientific journal PLoS One and demonstrate the need for more assertive interventions and regular physical health assessments to prevent premature death among these vulnerable groups. [9]
The BRC’s development of advanced computer programme to accurately detect the early signs of Alzheimer's disease from a routine clinical brain scan was reported in the media in 2011. The 'Automated MRI' software automatically compares or benchmarks someone’s brain scan image against 1200 others, each showing varying stages of Alzheimer’s disease. [10]
On 18th August 2011, the Department of Health announced that the Trust and the Institute of Psychiatry, King’s College London would receive a further £48.8m to continue running the Biomedical Research Centre for Mental Health for a further five years from 1 April 2012. An additional £4.5m was been awarded to the Trust to launch for a new NIHR Biomedical Research Unit for Dementia. [11] [12] [13]
The Trust is a member of the King's Health Partners academic health sciences centre, together with King's College London, Guy's and St Thomas' NHS Foundation Trust and King's College Hospital NHS Foundation Trust.
In partnership with the Institute of Psychiatry, King's College London, the Trust runs the National Addiction Centre (NAC), which aims to develop new treatment services for alcohol, smoking and drug problems. This work ranges from trials of new therapies and preventative treatments, to studies seeking to understand the genetic and biological basis of addictive behaviour.
An examples of research in this field is the Randomised Injecting Opioid Treatment Trial (RIOTT), a major scientific trial to evaluate a new style of treatment for people with the most severely entrenched heroin addiction. The trial involved use of using supervised injection of methadone and diamorphine, under controlled clinical conditions. It showed that it is possible to engage and retain in treatment some of the most entrenched hard-to-treat heroin addicts for whom previous treatment, rehabilitation and prison appear to have had little beneficial impact. [14]
|
|
|